Derek K. Chu February 20, 2021
J Allergy Clin Immunol Pract. 2021 Feb 16. Clinical Implications: In 2 randomized studies addressing peanut allergy (Canada-Food Allergy Risk Management 1 [NCT01812798] and Peanut Immunotherapy Starting in Canada, Evaluation and DiScovery [NCT01601522]), we quantified peanut allergen thresholds to food challenge using Bayesian stacked model averaging to inform policy and clinical practice. About 50% of patients tolerated more than 70 mg (w1/4 peanut).  PMID:33607344 | DOI:10.1016/j.jaip.2021.02.009

Full text access may require purchase from the publisher, or a login through your institution's library or computer network.